Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Application
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Ramipril-d5 is intended for use as an internal standard for the quantification of ramipril (Item No. 15558) by GC- or LC-MS. Ramipril is a prodrug form of the angiotensin converting enzyme (ACE) inhibitor ramiprilat (Item No. 15557).1 Ramipril (2.5 mg/kg per day, p.o.) reduces systolic blood pressure in spontaneously hypertensive rats.2 It reduces aortic valve backscatter and improves aortic flow in a rabbit model of aortic valve stenosis.3 Ramipril also decreases paw swelling and serum levels of TNF-α and prostaglandin E2 (PGE2) as well as cardiac collagen deposition and fibrosis in a rat model of adjuvant-induced arthritis.4
WARNING This product is not for human or veterinary use.
1. Protease inhibitors: Current status and future prospects. J. Med. Chem. 43(3), 305-341 (2000).
2. Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension. Hypertension 26(2), 236-243 (1995).
3. Ramipril retards development of aortic valve stenosis in a rabbit model: Mechanistic considerations. Br. J. Pharmacol. 162(3), 722-732 (2011).
4. Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis. Arthritis Res. Ther. 14(5), R223 (2012).